These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25833838)

  • 21. Loss of TR4 orphan nuclear receptor reduces phosphoenolpyruvate carboxykinase-mediated gluconeogenesis.
    Liu NC; Lin WJ; Kim E; Collins LL; Lin HY; Yu IC; Sparks JD; Chen LM; Lee YF; Chang C
    Diabetes; 2007 Dec; 56(12):2901-9. PubMed ID: 17827404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.
    Shin YJ; Kim JH
    PLoS One; 2012; 7(1):e30393. PubMed ID: 22272343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-secreted Hsp90 subverts polycomb function to drive prostate tumor growth and invasion.
    Nolan KD; Franco OE; Hance MW; Hayward SW; Isaacs JS
    J Biol Chem; 2015 Mar; 290(13):8271-82. PubMed ID: 25670862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression.
    Shi H; Sun Y; He M; Yang X; Hamada M; Fukunaga T; Zhang X; Chang C
    Oncogene; 2020 Jan; 39(3):530-545. PubMed ID: 31501521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress stimulates testicular orphan receptor 4 through forkhead transcription factor forkhead box O3a.
    Li G; Lee YF; Liu S; Cai Y; Xie S; Liu NC; Bao BY; Chen Z; Chang C
    Endocrinology; 2008 Jul; 149(7):3490-9. PubMed ID: 18388194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer.
    Takayama K; Suzuki T; Tsutsumi S; Fujimura T; Urano T; Takahashi S; Homma Y; Aburatani H; Inoue S
    Oncotarget; 2015 Feb; 6(4):2263-76. PubMed ID: 25537508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen receptor α-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer.
    Shen Y; Cao J; Liang Z; Lin Q; Wang J; Yang X; Zhang R; Zong J; Du X; Peng Y; Zhang J; Shi J
    Cell Commun Signal; 2019 May; 17(1):50. PubMed ID: 31122254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of hepatitis B virus core promoter by the nuclear orphan receptor TR4.
    Lin WJ; Li J; Lee YF; Yeh SD; Altuwaijri S; Ou JH; Chang C
    J Biol Chem; 2003 Mar; 278(11):9353-60. PubMed ID: 12522137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
    Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
    Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease.
    Du L; Bergsneider M; Mirsadraei L; Young SH; Jonker JW; Downes M; Yong WH; Evans RM; Heaney AP
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8555-60. PubMed ID: 23653479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
    Williamson SC; Hepburn AC; Wilson L; Coffey K; Ryan-Munden CA; Pal D; Leung HY; Robson CN; Heer R
    PLoS One; 2012; 7(11):e48944. PubMed ID: 23145034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer stem cell differentiation: TGFβ1 and versican may trigger molecules for the organization of tumor spheroids.
    Oktem G; Sercan O; Guven U; Uslu R; Uysal A; Goksel G; Ayla S; Bilir A
    Oncol Rep; 2014 Aug; 32(2):641-9. PubMed ID: 24927163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma.
    Chen Y; Lu J; Xia L; Xue D; Yu X; Shen D; Xu L; Li G
    Cancer Sci; 2018 Feb; 109(2):384-394. PubMed ID: 29197138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
    Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
    Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collaboration of Kras and androgen receptor signaling stimulates EZH2 expression and tumor-propagating cells in prostate cancer.
    Cai H; Memarzadeh S; Stoyanova T; Beharry Z; Kraft AS; Witte ON
    Cancer Res; 2012 Sep; 72(18):4672-81. PubMed ID: 22805308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.
    Zhang Y; Lin C; Liao G; Liu S; Ding J; Tang F; Wang Z; Liang X; Li B; Wei Y; Huang Q; Li X; Tang B
    Oncotarget; 2015 Oct; 6(32):32586-601. PubMed ID: 26452129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer.
    Liu Q; Wang G; Li Q; Jiang W; Kim JS; Wang R; Zhu S; Wang X; Yan L; Yi Y; Zhang L; Meng Q; Li C; Zhao D; Qiao Y; Li Y; Gursel DB; Chinnaiyan AM; Chen K; Cao Q
    Int J Cancer; 2019 Jul; 145(2):415-426. PubMed ID: 30628724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TR4 orphan nuclear receptor functions as an apoptosis modulator via regulation of Bcl-2 gene expression.
    Kim E; Ma WL; Lin DL; Inui S; Chen YL; Chang C
    Biochem Biophys Res Commun; 2007 Sep; 361(2):323-8. PubMed ID: 17655826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
    Rentala S; Mangamoori LN
    J Stem Cells; 2010; 5(2):75-81. PubMed ID: 22049617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditionally replicative adenovirus carrying shRNA targeting EZH2 inhibits prostate cancer growth and invasion.
    Xu SG; Yu JJ; Shi Q; Niu Q; Guo Z; Guo BY; Zhou GC; Gu X; Wu YX
    Oncol Rep; 2019 Jul; 42(1):273-282. PubMed ID: 31115564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.